PLD3 and amyloidosis: Remarkably, disease function analyses identified nine proteins previously described as being altered in AD and amyloidosis diseases (APOA4, HSPA5, RNASET2, PLD3, FRMD4B, B2M, HPX, SERPINC1, OLR1).